- Home
- WRBY vs CRNX Comparison
WRBY vs CRNX Comparison
Compare WRBY & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- CRNX
- Stock Information
- Founded
- WRBY 2010
- CRNX 2008
- Country
- WRBY United States
- CRNX United States
- Employees
- WRBY N/A
- CRNX N/A
- Industry
- WRBY Ophthalmic Goods
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- CRNX Health Care
- Exchange
- WRBY Nasdaq
- CRNX Nasdaq
- Market Cap
- WRBY 2.7B
- CRNX 2.8B
- IPO Year
- WRBY 2021
- CRNX 2018
- Fundamental
- Price
- WRBY $26.75
- CRNX $34.00
- Analyst Decision
- WRBY Buy
- CRNX Strong Buy
- Analyst Count
- WRBY 16
- CRNX 7
- Target Price
- WRBY $24.40
- CRNX $74.33
- AVG Volume (30 Days)
- WRBY 1.4M
- CRNX 1.1M
- Earning Date
- WRBY 11-06-2025
- CRNX 11-11-2025
- Dividend Yield
- WRBY N/A
- CRNX N/A
- EPS Growth
- WRBY N/A
- CRNX N/A
- EPS
- WRBY N/A
- CRNX N/A
- Revenue
- WRBY $821,347,000.00
- CRNX $1,392,000.00
- Revenue This Year
- WRBY $17.17
- CRNX $489.51
- Revenue Next Year
- WRBY $14.53
- CRNX $661.93
- P/E Ratio
- WRBY N/A
- CRNX N/A
- Revenue Growth
- WRBY 14.09
- CRNX 0.51
- 52 Week Low
- WRBY $13.63
- CRNX $24.10
- 52 Week High
- WRBY $29.73
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- WRBY 57.13
- CRNX 57.57
- Support Level
- WRBY $26.63
- CRNX $33.19
- Resistance Level
- WRBY $27.59
- CRNX $37.23
- Average True Range (ATR)
- WRBY 0.68
- CRNX 1.49
- MACD
- WRBY -0.01
- CRNX 0.23
- Stochastic Oscillator
- WRBY 67.69
- CRNX 55.87
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.